{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:56:32Z","timestamp":1767938192544,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004789","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000}}],"reference-count":92,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004789.pub2","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T10:08:51Z","timestamp":1097748531000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["D-penicillamine for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[{"name":"Bispeberg Bakke 26C, 2.th Copenhagen NV Denmark 2400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Louise","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; Cochrane Hepato-Biliary Group; Rigshospitalet, Dept. 3344 Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"key":"10.1002\/14651858.CD004789.pub2-BIB0001|cit1","first-page":"A909","article-title":"Controlled trial of high and low dose D-penicillamine (DP) in primary biliary cirrhosis (PBC): results at three years (abstract)","volume":"23","author":"Bassendine","year":"1982","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0002|cit2","first-page":"166","article-title":"Controlled trial of D-penicillamine in primary biliary cirrhosis: incidence of side effects and relation to dose (IASL abstract)","volume":"2","author":"Macklon","year":"1982","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0003|cit3","first-page":"845","article-title":"Immunologic effects of penicillamine in patients with primary biliary cirrhosis","volume":"3","author":"Bodenheimer","year":"1983","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0016-5085(85)90500-1","article-title":"Effects of penicillamine on serum immunoglobulins and immune complex-reactive material in primary biliary cirrhosis","volume":"88","author":"Bodenheimer","year":"1985","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD004789.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840050613","article-title":"A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0006|cit6","first-page":"168","article-title":"A two dose level randomized double blind controlled trial of penicillamine in primary biliary cirrhosis","volume":"2","author":"Schaffner","year":"1982","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0016-5085(77)80012-7","article-title":"Effect of D-penicillamine on copper retention in patients with primary biliary cirrhosis","volume":"72","author":"Deering","year":"1977","journal-title":"Gastroenterology"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD004789.pub2-BIB0010|cit8","first-page":"121","article-title":"The syndrome of primary biliary cirrhosis","volume":"8","author":"Dickson","year":"1981","journal-title":"Journal of Rheumatology"},{"issue":"16","key":"10.1002\/14651858.CD004789.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0009|cit10","first-page":"1225","article-title":"D-penicillamine improves survival and retards histologic progression in primary biliary cirrhosis (abstract)","volume":"82","author":"Dickson","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hep.510230108","article-title":"Time course of histological progression in primary biliary cirrhosis","volume":"23","author":"Locke","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD004789.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0190-9622(83)70166-0","article-title":"Primary biliary cirrhosis and lichen planus","volume":"9","author":"Powell","year":"1983","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jama.1982.03330010003001","article-title":"Penicillaine therapy 'encouraging' in primary biliary cirrhosis study","volume":"248","author":"Reed","year":"1982","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0014|cit14","first-page":"1032","article-title":"D-penicillamine and clinical trials in PBC (AASLD abstract)","volume":"4","author":"Epstein","year":"1984","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0015|cit15","first-page":"A1134","article-title":"D-penicillamine in primary biliary cirrhosis (PBC) - an untested (and untestable?) treatment (abstract)","volume":"25","author":"Epstein","year":"1984","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0016|cit16","first-page":"A433","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis (abstract)","volume":"22","author":"Epstein","year":"1981","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM197902083000602","article-title":"Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis","volume":"300","author":"Epstein","year":"1979","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0019|cit19","first-page":"A994","article-title":"Effect of penicillamine on immune complexes and immunoglobulins in primary biliary cirrhosis (PBC) (abstract)","volume":"19","author":"Epstein","year":"1978","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0020|cit20","first-page":"523","article-title":"A controlled trial of D-penicillamine therapy in primary biliary cirrhosis and chronic active hepatitis (abstract)","volume":"14","author":"Jain","year":"1976","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(77)92778-7","article-title":"A controlled trial of D-penicillamine therapy in primary biliary cirrhosis","volume":"16","author":"Jain","year":"1977","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0022|cit22","first-page":"822","article-title":"A controlled trial of D-penicillamine therapy in primary biliary cirrhosis (abstract)","volume":"17","author":"Jain","year":"1976","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD004789.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0024|cit24","first-page":"579A","article-title":"D-penicillamine does not alter the course of primary biliary cirrhosis (abstract)","volume":"27","author":"Matloff","year":"1979","journal-title":"Clinical Research"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0025|cit25","first-page":"G31","article-title":"D-penicillamine in primary biliary cirrhosis: preliminary results of an international trial (EASL abstract)","volume":"4","author":"Neuberger","year":"1984","journal-title":"Liver"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0026|cit26","first-page":"A968","article-title":"D-penicillamine in primary biliary cirrhosis: preliminary results of an international trial (abstract)","volume":"24","author":"Neuberger","year":"1983","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD004789.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0030|cit28","first-page":"228","article-title":"Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy","volume":"23","author":"Taal","year":"1985","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0031|cit29","first-page":"1351","article-title":"Prednisone plus D-penicillamine, D-penicillamine and placebo compared in primary biliary cirrhosis syndrome (abstract)","volume":"80","author":"Taal","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0028|cit30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0676.1983.tb00887.x","article-title":"Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis","volume":"3","author":"Taal","year":"1983","journal-title":"Liver"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0029|cit31","first-page":"547","article-title":"A double-blind controlled trial of D-penicillamine for PBC: the dose dependent effect (abstract)","volume":"126","author":"Taal","year":"1982","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD004789.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-9343(82)90178-4","article-title":"Immune complexes in primary biliary cirrhosis: high prevalence of circulating immune complexes in patients with associated autoimmune features","volume":"73","author":"Gupta","year":"1982","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.24.2.136","article-title":"Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis","volume":"24","author":"Savolainen","year":"1983","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD004789.pub2-BIB0034|cit34","first-page":"A919","article-title":"D-penicillamine in primary biliary cirrhosis: two year results of a single centre, double-blind controlled trial","volume":"21","author":"Triger","year":"1980","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD004789.pub2-BIB0035|cit35","article-title":"Cochrane Reviewers' Handbook 4.2.1[updated December 2003]","author":"Alderson","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","article-title":"Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"ii","author":"Ballardini","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004789.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: a progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0042|cit42","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch16","article-title":"Effect measures for meta-analysis of trials with binary outcomes","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0043|cit43","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examing heterogeneity and combing results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-75-1-57","article-title":"Long term therapy of Wilson's disease","volume":"75","author":"Deiss","year":"1971","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7109","key":"10.1002\/14651858.CD004789.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM197902083000602","article-title":"Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis","volume":"300","author":"Epstein","year":"1979","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004789.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","article-title":"The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"83","author":"Epstein","year":"1982","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD004789.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.142.11.3815","article-title":"Antimitochondrial antibodies of primary biliary cirrhosis recongnize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex","volume":"142","author":"Fregeau","year":"1989","journal-title":"Journal of Immunology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/sim.1183","article-title":"Investigating causes of heterogeneity in systematic reviews","volume":"21","author":"Glasziou","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0053|cit53","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe - First Report by the Gastroenterology Across Frontiers Panel","volume":"6","author":"Gluud","year":"1993","journal-title":"Gastroenterology International"},{"issue":"2","key":"10.1002\/14651858.CD004789.pub2-BIB0054|cit54","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"issue":"5 Pt. 1","key":"10.1002\/14651858.CD004789.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD004789.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0060|cit60","volume-title":"Code of Federal Regulation & ICH Guidelines","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8233","key":"10.1002\/14651858.CD004789.pub2-BIB0063|cit63","first-page":"1278","article-title":"Primary biliary cirrhosis - a revised clinical spectrum","volume":"1","author":"James","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1002\/14651858.CD004789.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD004789.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a U.S. community","volume":"119","author":"Kim","year":"2000","journal-title":"Gatroenterology"},{"issue":"11","key":"10.1002\/14651858.CD004789.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004789.pub2-BIB0069|cit69","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD004789.pub2-BIB0070|cit70","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI109759","article-title":"Inhibition of human helper T cell function in vitro by D-penicillamine and copper sulfate","volume":"65","author":"Lipsky","year":"1980","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"issue":"9039","key":"10.1002\/14651858.CD004789.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"9128","key":"10.1002\/14651858.CD004789.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0077|cit77","first-page":"220","article-title":"Collagen defect induced by D-penicillamine","volume":"240","author":"Nimni","year":"1972","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD004789.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4 Pt2","key":"10.1002\/14651858.CD004789.pub2-BIB0080|cit80","first-page":"171A","article-title":"Symptom development and prognosis of initially asymptomatic PBC","volume":"32","author":"Prince","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gatroenterology"},{"issue":"12","key":"10.1002\/14651858.CD004789.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004789.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.1964.03070100042008","article-title":"Penicillamine therapy for hepatolenticular degeneration","volume":"189","author":"Sternlieb","year":"1964","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004789.pub2-BIB0085|cit85","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Oord","year":"1986","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD004789.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004789.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004789.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD004789.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004789.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.1840060309","article-title":"Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis","volume":"6","author":"Yamada","year":"1986","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004789.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/EBG.0b013e31805c9d32","article-title":"D-penicillamine vs placebo\/no intervention in patients with primary biliary cirrhosis","volume":"8","author":"Gong","year":"2007","journal-title":"Evidence-Based Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004789.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T08:01:53Z","timestamp":1766736113000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004789.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":92,"aliases":["10.1002\/14651858.cd004789","10.1002\/14651858.cd004789"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004789.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]}}}